Application progress of telemedicine in bipolar disorder patients under the COVID-19 pandemic
Pages 243 - 246
Abstract
Bipolar disorder (BD) is a highly pathological disorder that is often misdiagnosed or undiagnosed. The main treatment is a combination of psychotherapy and medication. Traditional psychotherapy is affected by factors such as time, space, shortage of professional psychotherapists and patients' stigma, and has low availability. In terms of drug therapy, patients' medication compliance is poor, leading to repeated illness. The epidemic of coronavirus in 2019, closed management and telemedicine provide new ideas for the treatment of BD. Telemedicine can provide convenient medical services, promote disease rehabilitation, effectively guide patients' self-management, improve patients' treatment compliance, and prevent disease recurrence. This paper analyzes and summarizes the research related to telemedicine in BD, including the origin and significance, technical methods and application effects. To provide a reference for the application of telemedicine in patients with BD.
References
[1]
Grande I, Berk M, Birmaher B, Bipolar disorder [J]. Lancet, 2016, 387 (10027): 1561.
[2]
World Health Organization. The global burden of disease: 2004 update [M]. Geneva: WHO, 2008: 35.
[3]
Fagiolini A, Forgione R, Maccari M, Prevalence, chronicity, burden and borders of bipolar disorder [J]. J Affect Disorders, 2013, 148 (2/3): 161-169
[4]
Reinares M, Sánchez-Moreno J, Fountoulakis KN. Psychosocial interventions in bipolar disorder: what, for whom, and when [J]. J Affect Disorders, 2014, 156 (5): 46-55.
[5]
Clement S, Schauman O, Graham T, What is the impact of mental health-related stigma on help-seeking? A systematic review of quantitative and qualitative studies [J]. Psychol Med, 2015, 45 (1): 11-27.
[6]
Pratt SI, Naslund JA, Wolfe RS, Automated telehealth for managing psychiatric instability in people with serious mental illness [J]. J Ment Heal, 2014, (5): 1.
[7]
World Health Organization. Telemedicine: opportunities and developments in member states [C]. Report on the second global survey on eHealth, 2010.
[8]
Uslu E, Bulduko lu K. The effect of tele-nursing practices to the schizophrenia patient care: a systematic review [J]. Turkish J Psychiatry, 2016, 27 (1): 47
[9]
Pangka KR, Chandrasena R, Wijeratne N, Exploring the views of emergency department staff on the use of videoconferencing for mental health emergencies in southwestern Ontario [J]. Stud Health Technol Inform, 2015, 209: 114-120.
[10]
Faurholt-Jepsen M, Frost M, Christensen EM, The association between mixed symptoms, irritability and functioning measured using smartphones in bipolar disorder. Acta Psychiatr Scand [J]. 2019, 139(5): 443-453.
[11]
Barnes CW, Hadzipavlovic D, Wilhelm K, A web-based preventive intervention program for bipolar disorder: outcome of a 12-months randomized controlled trial [J]. J Affective Disorders, 2015, 174 (4): 485-492
[12]
Todd N J, Jones SH, Hart A, A web-based self-management intervention for Bipolar Disorder ‘living with bipolar’: a feasibility randomised controlled trial [J]. J Affect Disord, 2014, 169 (4): 21-29
[13]
Hidalgomazzei D, Reinares M, Mateu A, Is a Simple smartphone application capable of improving biological rhythms in bipolar disorder? [J]. J Affective Disorders, 2017, 223: 10.
[14]
Kernebeck S, Busse TS, Böttcher MD, Impact of mobile health and medical applications on clinical practice in gastroenterology. World J Gastroenterol. 2020, 7; 26(29): 4182-4197.
[15]
Javelot H, Spadazzi A, Weiner L, Telemonitoring with respect to mood disorders and information and communication technologies: overview and presentation of the psyche project [J]. Biomed Res Int, 2014, 2014 (4): 104658
[16]
Proudfoot J, Parker G, Manicavasagar V, Effects of adjunctive peer support on perceptions of illness control and understanding in an online psychoeducation program for bipolar disorder: a randomised controlled trial [J]. J Affective Disorders, 2012, 142 (1/3): 98-105
[17]
Bilderbeck AC, Saunders KE, Price J, Psychiatric assessment of mood instability: qualitative study of patient experience [J]. Br J Psychiatry, 2014, 204 (3): 234-239.
[18]
Montes JM, Maurino J, Dios CD, Suboptimal treatment adherence in bipolar disorder: impact on clinical outcomes and functioning [J]. Patient Prefer Adher, 2013, 7 (default): 89
[19]
Levin JB, Moore DJ, Depp C, Using mHealth to improve adherence and reduce blood pressure in individuals with hypertension and bipolar disorder (iTAB-CV): study protocol for a 2-stage randomized clinical trial [J]. Trials, 2022, 29; 23(1): 53.
Index Terms
- Application progress of telemedicine in bipolar disorder patients under the COVID-19 pandemic
Index terms have been assigned to the content through auto-classification.
Recommendations
Analyzing the Use of Telemedicine as Health Consultation due to COVID-19 Pandemic in Indonesia Context
ICSIM '22: Proceedings of the 2022 5th International Conference on Software Engineering and Information ManagementThe COVID-19 pandemic has hampered all human activities, both from the economic sector, entertainment and the most impactful, namely the health sector. This situation results in health facilities being unable to treat patients who have minor illnesses. ...
Musculoskeletal Telemedicine Trends Preceding the COVID-19 Pandemic and Potential Implications of Rapid Telemedicine Expansion
Introduction. Telemedicine was rapidly deployed at the onset of the COVID-19 pandemic. Little has been published on telemedicine in musculoskeletal care prior to the COVID-19 pandemic. This study is aimed at characterizing trends in telemedicine for ...
Efficacy of Telemedicine Utilization for Cardiac Outpatients’ Care during the Pandemic of COVID-19: A Large Center Experience in the Wave of the Pandemic
Introduction. Synchronous telemedicine using teleconferencing may play a role in clinical care. In a tertiary care center, video conferencing-enhanced virtual clinics were established via a new application platform. They were introduced ...
Comments
Information & Contributors
Information
Published In
October 2022
594 pages
ISBN:9781450398442
DOI:10.1145/3570773
Copyright © 2022 ACM.
Permission to make digital or hard copies of all or part of this work for personal or classroom use is granted without fee provided that copies are not made or distributed for profit or commercial advantage and that copies bear this notice and the full citation on the first page. Copyrights for components of this work owned by others than ACM must be honored. Abstracting with credit is permitted. To copy otherwise, or republish, to post on servers or to redistribute to lists, requires prior specific permission and/or a fee. Request permissions from [email protected]
Publisher
Association for Computing Machinery
New York, NY, United States
Publication History
Published: 09 December 2022
Check for updates
Qualifiers
- Research-article
- Research
- Refereed limited
Conference
ISAIMS 2022
ISAIMS 2022: 2022 3rd International Symposium on Artificial Intelligence for Medicine Sciences
October 13 - 15, 2022
Amsterdam, Netherlands
Acceptance Rates
Overall Acceptance Rate 53 of 112 submissions, 47%
Contributors
Other Metrics
Bibliometrics & Citations
Bibliometrics
Article Metrics
- 0Total Citations
- 38Total Downloads
- Downloads (Last 12 months)13
- Downloads (Last 6 weeks)0
Reflects downloads up to 28 Jan 2025
Other Metrics
Citations
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Sign inFull Access
View options
View or Download as a PDF file.
PDFeReader
View online with eReader.
eReaderHTML Format
View this article in HTML Format.
HTML Format